Test the Waters
Entelexo (yc W21)

Entelexo (yc W21)

Creating a new class of drugs to address incurable autoimmune diseases

Print
Security Type
Equity
Min Investment
$100
Location
Irvine, CA
Offering Date
April 15, 2021

Company Description

Developing new classes of drugs to address incurable autoimmune diseases

Perks

Invest $5,000+ Zoom call with the founders + lab tour
Invest $10,000+ Lunch + lab tour with the founders next time you're in town

Key Deal Facts

$553k raised to date, plus $310k on the same terms
CEO led the 1st clinical trials in the world evaluating exosomes as a treatment for autoimmune disease
Targeting 25M affected by immune-mediated diseases in US, equal to $150B in medical costs/year
Our intellectual property is patent-protected
Raising $2M for pre-clinical product development and IND enabling animal studies

Management Team / Advisory Board Bios

Milad Riazifar, CEO
Exosome biologist with 10+ years of experience in exosome research and clinical development. Led the first clinical trial using exosomes in autoimmune disease to treat Type 1 Diabetes.

Todd Schurr, COO
Multidisciplinary engineer with biomanufacturing experience. His expertise in cGMP manufacturing and process automation are key to streamlining the regulatory approval process.

Cameron Taylor, CTO
Biomedical engineer with extensive experience in stem cell biology and protein engineering. His expertise in gene editing is key to the development of the technology platform.
Amount Raised : $0
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Equity is a stock or any other security representing a direct ownership interest.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments